Investment Thesis
UFP Technologies exhibits strong topline growth (19.5% YoY) and solid profitability margins (11.3% net margin), but negative free cash flow (-$2.5M) and critically low returns on capital (4% ROE, 2.6% ROA) signal inefficient capital deployment. While the conservative balance sheet (0.31x debt/equity) prevents imminent distress, the disconnect between accounting profits and cash generation raises sustainability questions that must be resolved.
Strengths
- Strong revenue growth of 19.5% YoY in medical device sector with EPS growth of 15.4%
- Solid profitability with 11.3% net margin and 15.2% operating margin demonstrating operational efficiency
- Conservative capital structure with 0.31x debt/equity ratio and 4.3x interest coverage
- Strong liquidity position with 2.91x current ratio and 1.69x quick ratio
- Adequate gross margin of 28.8% indicating competitive positioning and pricing power
Risks
- Negative free cash flow of -$2.5M despite $17.5M net income indicates poor cash conversion and working capital concerns
- Operating cash flow of only $3.2M (2.1% of revenue) is inadequate for sustainable operations and debt servicing
- Critically low ROE (4.0%) and ROA (2.6%) demonstrate inefficient deployment of $438.9M equity and $674.7M assets
- Minimal cash reserves of $20M with negative FCF trends threaten financial flexibility and debt service capability
- Unexplained gap between profitability and cash generation suggests potential inventory bloat, receivables issues, or unsustainable practices
Key Metrics to Watch
- Free cash flow conversion and operating cash flow as percentage of revenue - must achieve positive FCF
- Return on Equity and Return on Assets trajectory - 4% and 2.6% are unacceptably low
- Days inventory outstanding and days sales outstanding - likely drivers of negative FCF
- Cash balance and debt service coverage ratio - sustainability of leverage with negative cash generation
- Capital expenditure intensity and depreciation trends - validate reinvestment requirements
Financial Metrics
Revenue
154.2M
Net Income
17.5M
EPS (Diluted)
$2.24
Free Cash Flow
-2.5M
Total Assets
674.7M
Cash
20.0M
Profitability Ratios
Gross Margin
28.8%
Operating Margin
15.2%
Net Margin
11.3%
ROE
4.0%
ROA
2.6%
FCF Margin
-1.6%
Balance Sheet & Liquidity
Current Ratio
2.91x
Quick Ratio
1.69x
Debt/Equity
0.31x
Debt/Assets
35.0%
Interest Coverage
4.26x
Long-term Debt
137.6M
Disclaimer: This analysis is generated by AI based on publicly available SEC EDGAR filings.
It does not include stock price data and should not be considered financial advice.
All fundamental data is sourced from SEC public domain filings.
Always conduct your own research before making investment decisions.
Data Source: SEC EDGAR |
Analysis Date: 2026-05-09T08:08:35.073801 |
Data as of: 2026-03-31 |
Powered by Claude AI